Dr. Gu is Managing Director at Sequoia China, focusing on healthcare investment especially in the biotech, innovative drug, molecular diagnostics and precision medicine sphere. Prior to joining Sequoia, she worked as an Associate at OrbiMed Asia team, focusing on healthcare and life sciences investments, including pharmas, biotechs, medical devices and healthcare services. Prior to joining OrbiMed, Dr. Gu worked as a Project Manager at Eli Lilly Global External Research and Development Department in Shanghai, where she was responsible for the collaborations, partnering and office operational activities. Prior, she was a Director for Development Planning at Shanghai Genomics, a biotech company focused on drug discovery and development. There, she managed in-licensing activities and IND-enabling studies for NCE development. Dr. Gu has a B.S. with double majors in Biotechnology and English, and a Ph.D. in Biochemistry and Molecular Biology, both from Shanghai Jiao Tong University.